A CONTINUOUS MODEL OF ANGIOGENESIS: INITIATION, EXTENSION, AND MATURATION OF NEW BLOOD VESSELS MODULATED BY VASCULAR ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETINS, PLATELET-DERIVED GROWTH FACTOR-B, AND PERICYTES

被引:36
|
作者
Zheng, Xiaoming [1 ]
Koh, Gou Young [2 ]
Jackson, Trachette [3 ]
机构
[1] Cent Michigan Univ, Dept Math, Mt Pleasant, MI 48859 USA
[2] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea
[3] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA
来源
DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES B | 2013年 / 18卷 / 04期
基金
新加坡国家研究基金会;
关键词
Angiogenesis; endothelial cells; pericytes; initiation; migration; maturation; vascular endothelial growth factor; Angiopoietin-1; Angiopoietin-2; Tie2; platelet-derived growth factor-B; viscoelastic model; corneal angiogenesis; antiangiogenic therapy; UP-REGULATES ANGIOPOIETIN-2; CAPILLARY NETWORK FORMATION; TUMOR-INDUCED ANGIOGENESIS; REINFORCED RANDOM-WALK; MATHEMATICAL-MODEL; SIGNAL-TRANSDUCTION; CELL SURVIVAL; NUMERICAL SIMULATIONS; VEGF RECEPTORS; TIE2; RECEPTOR;
D O I
10.3934/dcdsb.2013.18.1109
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
This work presents a continuous model for three early stage events in angiogenesis: initiation, sprout extension, and vessel maturation. We carefully examine the regulating mechanisms of vascular endothelial growth factor (VEGF) and angiopoietins (Ang1 and Ang2) on the proliferation, migration and maturation of endothelial cells through their endothelium-specific receptor tyrosine kinase VEGFR2 and Tie2, respectively. We also consider the effect of platelet-derived growth factor-B (PDGF-B) on the proliferation and migration of pericytes. For growth factors, we present a mathematical model integrating molecular reactions on blood vessels with tissue-level diffusion. For capillary extension, we develop a visco-elastic model to couple tip cell protrusion, endothelium elasticity, and stalk cell proliferation. Our model reproduces corneal angiogenesis experiments and several anti-angiogenesis therapy results. This model also demonstrates that (1) the competition between Ang1 and Ang2 is the angiogenic switch; (2) the maturation process modulated by pericytes and angiopoietins is crucial to vessel normalization and can explain the resistance to anti-VEGF therapy; (3) combined anti-pericyte and anti-VEGF therapy enhances blood vessel regression over anti-VEGF therapy alone.
引用
收藏
页码:1109 / 1154
页数:46
相关论文
共 50 条
  • [41] Expression levels of circulatory mir-185-5p, vascular endothelial growth factor, and platelet-derived growth factor target genes in endometriosis
    Razi, Mohammad Hossein
    Eftekhar, Maryam
    Ghasemi, Nasrin
    Sheikhha, Mohammad Hasan
    Firoozabadi, Ali Dehghani
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2020, 18 (05) : 347 - 358
  • [42] Dual neovascular targets of vascular endothelial growth factor receptors and platelet-derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats
    Xiong, Bin
    Bai, Yaowei
    Liu, Jiacheng
    Li, Tongqiang
    Wang, Yingliang
    Zhou, Chen
    PORTAL HYPERTENSION & CIRRHOSIS, 2024, 3 (01): : 1 - 13
  • [43] The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer
    Bran, Birgit
    Bran, Gregor
    Hoermann, Karl
    Riedel, Frank
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 34 (01) : 255 - 261
  • [44] Pulmonary Tumor Thrombotic Microangiopathy Caused by Urothelial Carcinoma Expressing Vascular Endothelial Growth Factor, Platelet-derived Growth Factor, and Osteopontin
    Wakabayashi, Yasushi
    Iwaya, Mai
    Akita, Mayo
    Takeuchi, Wataru
    Yamazaki, Kyohei
    Iijima, Akihiro
    INTERNAL MEDICINE, 2016, 55 (06) : 651 - 656
  • [45] Sustaining Neovascularization of a Scaffold Through Staged Release of Vascular Endothelial Growth Factor-A and Platelet-Derived Growth Factor-BB
    Davies, Neil H.
    Schmidt, Christian
    Bezuidenhout, Deon
    Zilla, Peter
    TISSUE ENGINEERING PART A, 2012, 18 (1-2) : 26 - 34
  • [46] Elevated platelet-derived growth factor-B in congenital cystic adenomatoid malformations requiring fetal resection
    Liechty, KW
    Crombleholme, TM
    Quinn, TM
    Cass, DL
    Flake, AW
    Adzick, NS
    JOURNAL OF PEDIATRIC SURGERY, 1999, 34 (05) : 805 - 809
  • [47] Structure-based discovery of novel small molecule inhibitors of platelet-derived growth factor-B
    Zarei, Omid
    Sarri, Niki
    Dastmalchi, Siavoush
    Zokai, Fateme
    Papadopoulos, Natalia
    Lennartsson, Johan
    Heldin, Carl-Henrik
    Hamzeh-Mivehroud, Maryam
    BIOORGANIC CHEMISTRY, 2020, 94
  • [48] Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia
    Pennock, Steven
    Kim, Leo A.
    Kazlauskas, Andrius
    MOLECULAR AND CELLULAR BIOLOGY, 2016, 36 (18) : 2314 - 2327
  • [49] The expression of thymidine phosphorylase platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer
    Yonenaga, F
    Takasaki, T
    Ohi, Y
    Sagara, Y
    Akiba, S
    Yoshinaka, H
    Aikou, T
    Miyadera, K
    Akiyama, S
    Yoshida, H
    PATHOLOGY INTERNATIONAL, 1998, 48 (11) : 850 - 856
  • [50] Stromal cell-derived factor 1 (SDF1) attenuates platelet-derived growth factor-B (PDGF-B)-induced vascular remodeling for adipose tissue expansion in obesity
    Eri Watanabe
    Tsutomu Wada
    Akira Okekawa
    Fuka Kitamura
    Go Komatsu
    Yasuhiro Onogi
    Seiji Yamamoto
    Masakiyo Sasahara
    Munehiro Kitada
    Daisuke Koya
    Hiroshi Tsuneki
    Toshiyasu Sasaoka
    Angiogenesis, 2020, 23 : 667 - 684